These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Prolongation of rat intestinal allograft survival by administration of donor interleukin-12 p35-silenced bone marrow-derived dendritic cells.
    Author: Xu H, Chen T, Wang HQ, Ji MJ, Zhu X, Wu WX.
    Journal: Transplant Proc; 2006 Jun; 38(5):1561-3. PubMed ID: 16797357.
    Abstract:
    Severe graft rejection remains an important obstacle in intestinal transplantation. In this study, we demonstrated that intravenous injection of interleukin (IL)-12 p35 siRNA-transfected dendritic cells (DCs) into recipient rats prolonged the survival of intestinal allografts. Serum IL-2 and interferon-gamma levels in the IL-12 p35 siRNA-transfected DCs treatment group were both significantly lower than in control groups at 7 days after transplantation. Further study is required to investigate the operative pathways and to optimize the strategy targeting dendritic cells to induce tolerance to intestinal allografts.
    [Abstract] [Full Text] [Related] [New Search]